• Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Contact Us
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

MIT Technology Review

The smartphone app that can tell you’re depressed before you know it yourself

October 15, 2018
Axios

Tesla’s former finance chief becomes CFO of genomics startup

October 8, 2018
The Pharma Letter

Insmed’s lung disease drug Arikayce approved in USA

September 29, 2018
CNBC

With life-threatening food allergies on the rise, drug companies ramp up new approaches

September 27, 2018
Tech.Co

Health by Mindstrong: The App That Can Diagnose Depression

September 18, 2018
Pulmonary Fibrosis News

FDA Puts FibroGen’s Pamrevlumab on Fast Track as IPF Treatment

September 14, 2018
GenomeWeb

Bristol-Myers Squibb to Use Natera’s Cell-Free DNA Assay in Immunotherapy Study

September 14, 2018
GenomeWeb

Gene Editing Company Inscripta Acquires Solana Biosciences

September 5, 2018
San Francisco Business Times

Months before drug launch, this Peninsula company drew people to get its sweat stopper

September 4, 2018
CNBC

SoftBank-backed 10x Genomics makes a clever buy to help unlock the human biological code

August 28, 2018
Page 14 of 26« First«...1213141516...20...»Last »

Please see important disclaimers in the Terms section.


©2026 Foresite Capital Management, LLC. Site by GOODLAB

    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
    Close
    • News
    • Blog
    • Foresite Labs
    • Contact Us
    • Home
    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
      • Blog
      • Careers
      • Contact Us
      • Disclosures
      • Home
      • Legal Disclaimers
      • Pardes Biosciences Legend
      • Privacy Policy
      • Strategy
      • Terms

    ©[current_date] Foresite Capital Management, LLC.

    Site by Goodlab

    Close